Study of Longterm Outcomes in Imprinting Disorders (SOLiD)

Medical School Banner Picture

Group leader: Dr Renuka Dias

Overview

Many imprinting disorders are characterised by abnormal growth, both in fetal and postnatal life. However the long-term health outcomes are unknown. We aim to undertake detailed research in people diagnosed with imprinting disorders from childhood into adulthood to better understand the risks to long-term health and the underlying mechanisms.

We are working in partnership with other clinicians across the UK to improve the overall care for children and adults with imprinting disorders.

SOLiD Logo

Our research group

Abnormal fetal growth has been linked to a number of metabolic diseases in adulthood, particularly Type 2 diabetes and cardiovascular disease (e.g. hypertension). Imprinting disorders are often associated with abnormal growth both pre-natally and post-natally. However, a link with adult disease is not well documented. The SOLiD team are interested in:

  • The epigenetics of imprinting disorders
  • The long-term health outcomes of imprinting disorders
Photograph of SOLiD Nursing Team

Current Projects

Our current research projects include an NIHR Portfolio Study (UKCRN ID 13914) in Silver-Russell Syndreme (SRS) and Beckwith-Wiedemann Syndrome (BWS). This study is looking at

  • novel genes involved to try and improve diagnosis rates in SRS
  • aspects of Growth and Development
  • the risk of developing other conditions (such as Type 2 diabetes)

Recent Publications

Staff

Principal Investigator
Dr Renuka Dias (r.dias.1@bham.ac.uk) - School of Clinical and Experimental Medicine

Internal Collaborators
Professor Tim Barrett - School of Clinical and Experimental Medicine

NHS Collaborators
Kayleigh Aston - Study Co-ordinator, University Hospitals Birmingham NHS Trust, UK
Wendy Donoghue - Research Nurse, University Hospitals Birmingham NHS Trust, UK

External Collaborators
Professor Eamonn Maher - University of Cambrige